Pomalyst (Pomalidomide) (4 Milligram, Capsules)


Indications and Reactions:

Role Indications Reactions
Primary
Plasma Cell Myeloma 98.0%
Product Used For Unknown Indication 1.5%
Pruritus 0.5%
Rash 9.5%
White Blood Cell Count Decreased 9.5%
Drug Intolerance 7.4%
Plasma Cell Myeloma 7.4%
Somnolence 7.4%
Neutropenia 5.3%
Tremor 5.3%
Fatigue 4.2%
Full Blood Count Decreased 4.2%
No Therapeutic Response 4.2%
Pneumonia 4.2%
Pruritus 4.2%
Pulmonary Embolism 4.2%
Renal Failure 4.2%
Adverse Drug Reaction 3.2%
Laboratory Test Abnormal 3.2%
Malaise 3.2%
Platelet Count Decreased 3.2%
Pyrexia 3.2%
Vomiting 3.2%
Secondary
Plasma Cell Myeloma 100.0%
Swelling Face 100.0%

Drug Data